Study of Magrolimab Combinations in Participants With Myeloid Malignancies
Clinical trial NCT04778410 · TERMINATED
Trial details
- NCT number
- NCT04778410
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-28
- Primary completion
- 2024-03-04
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.